Sequoia China has led a US$50 million series C round in Suzhou-based antibody discovery and development firm Adagene Inc.
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access thousands of news articles and data posts over the past 9 years!
Already have an account or paid subscription?